<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170514033961N8</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-11-08</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>"Evaluation of the effect of Leech Therapy on knee osteoarthritis"</public_title>
      <acronym></acronym>
      <scientific_title>Assessment of the effect of Leech Therapy on knee osteoarthritis pain and daily functioning of the elderly</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/58521</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: This study has an intervention group and a control group for comparison, Randomization description: Samples are placed in two groups of intervention and control group using random blocks (4). The method of assigning 80 samples to the two groups of intervention and control will be such that considering gender (male_woman) and body mass index (normal category and overweight category) as a class, the method of 4 random blocks for Assigning patients to two groups A (intervention) and group B (control) will be used. The normal category is the body mass index (18.5_25) and the overweight category (25_30). To do this, in older men and women, first a list of blocks will be written and numbers will be assigned to them. - ABAB (2) -ABBA (3) -BBAA (4) - BABA (5) - BAAB (6)) Then using a table of random numbers and randomly select numbers between 1 to 6 and finally the list of treatment assignments based on A sequence of letters A and B will be formed. Depending on the type of intervention and the awareness of the samples of the intervention they receive, blinding is not possible in the participants. But to reduce bias, we will try not to let the data collector and statistical analyst know which information belongs to which group.</study_design>
      <phase>2</phase>
      <hc_freetext>osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In addition to routine treatment, a 30-minute leech therapy session using 6 to 8 medical leeches (sankumukhi type) in a clean, secluded room while maintaining patient privacy and following all coronavirus protection protocols in a traditional medicine clinic environment will be done.Also continue your treatment routine during the intervention. Intervention 2: Control group: They will receive routine treatment and will not receive any intervention from the researcher and will be considered for comparison with the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All potential data is released after unidentifiable individuals in the form of original message information

When:
The access period will start from 2021

To whom:
Based on evidence-based medicine, if it is effective in improving the symptoms in patients with osteoarthritis of the knee, this method can be used in the clinical environment and in order to strengthen the results of previous research, we will do this research..All researchers, teachers, and medical students can download the published article from the relevant journal.

Conditions:
Unidentifiable data will be made available to health researchers for the study of meta-analysis.

Where to obtain:
Send email to Mandana Saki m.saki@modares.ac.ir

How to obtain:
After sending the documents by the applicant researcher via email,the data will be sent two weeks later

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Saki Mandana</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 18, Rose Alley, Enghelab St., Khorramabad, Lorestan</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6819834525</zip>
        <telephone>+98 66 3331 6465</telephone>
        <email>mandana_saki@yahoo.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Saki Mandana</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 18, Rose Alley, Enghelab St., Khorramabad, Lorestan</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6819834525</zip>
        <telephone>+98 66 3331 6465</telephone>
        <email>mandana_saki@yahoo.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 60-74 (young elderly)
Independence of others in daily activities
Lack of neurological diseases associated with movement and balance disorders
Having grade 3 (middle class) osteoarthritis according to the American College of Rheumatology classification criteria
Having moderate pain based on visual analog scale with a score of (4-7)
Failure to perform physiotherapy and knee surgery in the last 12 months
Having satisfaction consciously to participate in the study
No coagulation disorders and cardiovascular disease according to clinical history
No use drugs
No history of joint replacement in the lower limb
No intra-articular injection of steroids in the last 6 months
Having a BMI (body mass index) above 18.5 and below 30
Have a daily performance score above 34
Do not use complementary medicine methods and herbs in the field of osteoarthritis</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>74 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Occurrence of acute medical conditions such as anaphylactic shock and stroke during the study
Elderly deaths during the study
Withdrawal from the study despite initial agreement
Sensitivity to leeches
Existence of cognitive disorders based on the physician's opinion and the patient's previous medical history
Secondary osteoarthritis in rheumatic diseases
Use of leech therapy individually in the control group or other complementary medicine methods in both groups</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In addition to routine treatment, a 30-minute leech therapy session using 6 to 8 medical leeches (sankumukhi type) in a clean, secluded room while maintaining patient privacy and following all coronavirus protection protocols in a traditional medicine clinic environment will be done.Also continue your treatment routine during the intervention</i_keyword>
      <i_keyword>Control group: They will receive routine treatment and will not receive any intervention from the researcher and will be considered for comparison with the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee pain score. Timepoint: At the beginning of the study (before the intervention) and 7, 14 and 28 days after the intervention. Method of measurement: Osteoarthritis Index of the University of Western Ontario and McMaster.</prim_outcome>
      <prim_outcome>Joint dryness score. Timepoint: At the beginning of the study (before the intervention) and 7, 14 and 28 days after the intervention. Method of measurement: Osteoarthritis Index of the University of Western Ontario and McMaster.</prim_outcome>
      <prim_outcome>Daily performance score. Timepoint: At the beginning of the study (before the intervention) and 7, 14 and 28 days after the intervention. Method of measurement: Osteoarthritis Index of the University of Western Ontario and McMaster.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khoram-Abad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-04</approval_date>
        <contact_name>Ethics Committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>Vice Chancellor for Research and Technology, Lorestan, Khorramabad, Road, Pardis University Complex University of Medical Sciences Khorramabad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
